Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Pavlina Andreeva-Gateva & Shenol Chakar. (2019) The place of trabectedin in the treatment of soft tissue sarcoma: an umbrella review of the level one evidence. Expert Opinion on Orphan Drugs 7:3, pages 105-115.
Read now
Read now
Rita De Sanctis, Andrea Marrari, Silvia Marchetti, Chiara Mussi, Luca Balzarini, Fabio Romano Lutman, Primo Daolio, Stefano Bastoni, Alexia Francesca Bertuzzi, Vittorio Quagliuolo & Armando Santoro. (2015) Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma. Drug Design, Development and Therapy 9, pages 5785-5791.
Read now
Read now
Articles from other publishers (9)
Sameer Rastogi, Kaushal Kalra, Parisa Manasa, Monali Rajawat & Varshil Mehta. (2020) Long lasting response of trabectedin in patient with gastric leiomyosarcoma with liver metastasis: an update to previous report. Future Science OA 6:1.
Crossref
Crossref
Emiliano Calvo, Analia Azaro, Jordi Rodon, Luc Dirix, Manon Huizing, Francis Mark Senecal, Patricia LoRusso, Lorrin Yee, Italo Poggesi, Jan de Jong, Spyros Triantos, Youn C. Park, Roland E. Knoblauch, Trilok V. Parekh, George D. Demetri & Margaret von Mehren. (2017) Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trial. Investigational New Drugs 36:3, pages 476-486.
Crossref
Crossref
George D. DemetriMargaret von MehrenRobin L. JonesMartee L. HensleyScott M. SchuetzeArthur StaddonMohammed MilhemAnthony EliasKristen GanjooHussein TawbiBrian A. Van TineAlexander SpiraAndrew DeanNushmia Z. KhokharYoun Choi ParkRoland E. KnoblauchTrilok V. ParekhRobert G. MakiShreyaskumar R. Patel. (2016) Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial. Journal of Clinical Oncology 34:8, pages 786-793.
Crossref
Crossref
Nobuhito Araki, Shunji Takahashi, Hideshi Sugiura, Takafumi Ueda, Tsukasa Yonemoto, Mitsuru Takahashi, Hideo Morioka, Hiroaki Hiraga, Toru Hiruma, Toshiyuki Kunisada, Akihiko Matsumine & Akira Kawai. (2016) Retrospective inter- and intra-patient evaluation of trabectedin after best supportive care for patients with advanced translocation-related sarcoma after failure of standard chemotherapy. European Journal of Cancer 56, pages 122-130.
Crossref
Crossref
Bruno Vincenzi, Luciano Stumbo, Giuseppina Maltese, Linda Cerbone, Mariella Spalato Ceruso, Giuseppe Badalamenti, Daniele Santini, Giuseppe Tonini, Anna Maria Frezza, Delia De Lisi & Marianna Silletta. (2015) Lack of Correlation Between Liver Tests Abnormalities and Trabectedin Efficacy in the Treatment of Soft Tissue Sarcoma: a Retrospective Study. Scientific Reports 5:1.
Crossref
Crossref
Karin Jordan, Franziska Jahn, Berit Jordan, Thomas Kegel, Carsten Müller-Tidow & Jörn Rüssel. (2015) Trabectedin: Supportive care strategies and safety profile. Critical Reviews in Oncology/Hematology 94:3, pages 279-290.
Crossref
Crossref
Akira Kawai, Nobuhito Araki, Hideshi Sugiura, Takafumi Ueda, Tsukasa Yonemoto, Mitsuru Takahashi, Hideo Morioka, Hiroaki Hiraga, Toru Hiruma, Toshiyuki Kunisada, Akihiko Matsumine, Takanori Tanase, Tadashi Hasegawa & Shunji Takahashi. (2015) Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study. The Lancet Oncology 16:4, pages 406-416.
Crossref
Crossref
Christian Leporini, Marinella Patanè, Francesca Saullo, Pierandrea Rende, Luca Gallelli, Eugenio Donato Di Paola, Rosa Toscano, Maria Lucia, Marco Rossi, Giovambattista De Sarro & Emilio Russo. (2014) A Comprehensive Safety Evaluation of Trabectedin and Drug–Drug Interactions of Trabectedin-Based Combinations. BioDrugs 28:6, pages 499-511.
Crossref
Crossref
Jean-Pascal Machiels, Arthur Staddon, Catherine Herremans, Chi Keung, Apexa Bernard, Charles Phelps, Nushmia Z. Khokhar, Roland Knoblauch, Trilok V. Parekh, Luc Dirix & Sunil Sharma. (2014) Impact of cytochrome P450 3A4 inducer and inhibitor on the pharmacokinetics of trabectedin in patients with advanced malignancies: open-label, multicenter studies. Cancer Chemotherapy and Pharmacology 74:4, pages 729-737.
Crossref
Crossref